IRIS
LABATE, ANGELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.801
AS - Asia 4.026
EU - Europa 1.852
SA - Sud America 899
Continente sconosciuto - Info sul continente non disponibili 257
AF - Africa 86
OC - Oceania 23
Totale 13.944
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.573
SG - Singapore 1.887
CN - Cina 915
IT - Italia 755
BR - Brasile 685
VN - Vietnam 371
IN - India 368
SE - Svezia 237
GB - Regno Unito 213
HK - Hong Kong 181
DE - Germania 164
CA - Canada 159
AR - Argentina 91
EE - Estonia 91
BD - Bangladesh 76
FI - Finlandia 65
RU - Federazione Russa 65
ID - Indonesia 44
MX - Messico 42
NL - Olanda 41
ZA - Sudafrica 41
EC - Ecuador 38
IQ - Iraq 34
RO - Romania 33
FR - Francia 29
JP - Giappone 29
CO - Colombia 25
PL - Polonia 25
ES - Italia 22
UA - Ucraina 22
AU - Australia 20
CL - Cile 17
PK - Pakistan 16
TR - Turchia 16
PY - Paraguay 14
SA - Arabia Saudita 13
AT - Austria 12
MA - Marocco 11
VE - Venezuela 11
CH - Svizzera 10
KR - Corea 10
PE - Perù 10
TN - Tunisia 10
UZ - Uzbekistan 10
EG - Egitto 9
GR - Grecia 9
JM - Giamaica 9
CZ - Repubblica Ceca 8
IE - Irlanda 8
AE - Emirati Arabi Uniti 6
IR - Iran 6
JO - Giordania 6
KZ - Kazakistan 6
UY - Uruguay 6
BE - Belgio 5
IL - Israele 5
PH - Filippine 5
A2 - ???statistics.table.value.countryCode.A2??? 4
DZ - Algeria 4
KE - Kenya 4
NP - Nepal 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
LT - Lituania 3
MD - Moldavia 3
MK - Macedonia 3
MT - Malta 3
MY - Malesia 3
NI - Nicaragua 3
RS - Serbia 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
EU - Europa 2
HN - Honduras 2
KW - Kuwait 2
LB - Libano 2
LU - Lussemburgo 2
NG - Nigeria 2
SC - Seychelles 2
SI - Slovenia 2
AM - Armenia 1
AW - Aruba 1
BW - Botswana 1
CU - Cuba 1
GT - Guatemala 1
HR - Croazia 1
KG - Kirghizistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
Totale 13.686
Salva come PNG Salva come JPEG
Città #
San Jose 1.167
Chandler 660
Singapore 651
Dallas 634
Ashburn 580
Santa Clara 326
Bengaluru 279
Hefei 275
Council Bluffs 242
Milan 235
Princeton 220
Lawrence 219
Hong Kong 175
Chicago 155
London 155
Beijing 149
Ho Chi Minh City 128
Wilmington 118
Munich 109
Hanoi 94
Des Moines 79
Los Angeles 75
Ottawa 75
Boardman 64
Phoenix 64
São Paulo 63
New York 53
Catanzaro 42
Turku 42
Shanghai 38
Rome 37
The Dalles 27
Guangzhou 25
Rio de Janeiro 24
Helsinki 23
Naples 23
Orem 22
San Francisco 22
Warsaw 21
Buffalo 20
Da Nang 20
Johannesburg 20
Chennai 19
Montreal 19
Redwood City 19
Seattle 19
Brooklyn 18
Columbus 18
Pune 18
Tokyo 18
Mexico City 17
Amsterdam 16
Atlanta 16
Norwalk 16
Redmond 16
Toronto 16
Belo Horizonte 15
Boston 15
Charlotte 15
Brasília 13
Curitiba 13
Miami 13
Stockholm 13
Shenzhen 12
Guayaquil 11
Fortaleza 10
Jakarta 10
Ninh Bình 10
Quito 10
Tashkent 10
Augusta 9
Boydton 9
Campinas 9
Guarulhos 9
Melbourne 9
Timisoara 9
Washington 9
Baghdad 8
Biên Hòa 8
Catania 8
Dhaka 8
Falls Church 8
Frankfurt am Main 8
Haiphong 8
Horia 8
Lima 8
New Delhi 8
Philadelphia 8
Santiago 8
St Petersburg 8
Thái Bình 8
Casalnuovo Di Napoli 7
Denver 7
Durban 7
Erbil 7
Florence 7
Istanbul 7
Mumbai 7
Paris 7
Piscataway 7
Totale 8.103
Salva come PNG Salva come JPEG
Nome #
Management of psychogenic non-epileptic seizures: a multidisciplinary approach 188
Genetics of reflex seizures and epilepsies in humans and animals 169
Rating Scale for Psychogenic Non-epileptic Seizures: Scale Development and Clinimetric Testing 150
Predictive factors of Status Epilepticus and its recurrence in patients with adult–onset seizures: A multicenter, long follow–up cohort study 150
Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy 147
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy 131
A brainstem hypermetabolism in a patient with essential palatal tremor: A simultaneous 18F-FDG-PET/3 T-MRI study 108
Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study 102
A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy 99
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST) 98
Temporal lobe abnormalities on brain MRI in healthy volunteers: a prospective case-control study 97
3-T magnetic resonance imaging simultaneous automated multimodal approach improves detection of ambiguous visual hippocampal sclerosis. 96
A Functional Genetic Variation of the 5-HTR2A Receptor Affects Age at Onset in Patients with Temporal Lobe Epilepsy 90
Asymmetry of Permutation Entropy in Early Creutzfeldt-Jakob Disease: A Clue to a Specific Pathological Process? 90
Neocortical thinning in “benign” mesial temporal lobe epilepsy 85
Erratum: Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals (The American Journal of Human Genetics (2021) 108(6) (965–982), (S0002929721001403), (10.1016/j.ajhg.2021.04.009)) 84
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 80
Advanced morphological neuroimaging study in lateral temporal lobe epilepsy: A multicentric study 77
A puzzling case without solution: isolated late-onset epileptic seizure 76
Age at onset predicts good seizure outcome in sporadic non-lesional and mesial temporal sclerosis based temporal lobe epilepsy 76
White matter abnormalities across different epilepsy syndromes in adults: an ENIGMA-Epilepsy study 75
Network-based atrophy modeling in the common epilepsies: A worldwide ENIGMA study 74
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability 74
A new Italian instrument for the assessment of irritability in patients with epilepsy. 73
A Loss-of-Function HCN4 Mutation Associated With Familial Benign Myoclonic Epilepsy in Infancy Causes Increased Neuronal Excitability 73
Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk Study 72
Long-term outcome of mild mesial temporal lobe epilepsy 71
Facemask headache: a new nosographic entity among healthcare providers in COVID-19 era 71
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 70
Perampanel as first add-on choice on the treatment of mesial temporal lobe epilepsy: an observational real-life study 70
A novel mutation in the Notch3 gene in an Italian family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: genetic and magnetic resonance spectroscopic findings 69
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures 69
The Ketogenic Diet in Children with Epilepsy: A Focus on Parental Stress and Family Compliance 68
Effectiveness of perampanel as the only add‐on: Retrospective, multicenter, observational real‐life study on epilepsy patients 67
Kufs disease due to mutation of CLN6: clinical, pathological and molecular genetic features. 67
Circulating microrna: The potential novel diagnostic biomarkers to predict drug resistance in temporal lobe epilepsy, a pilot study 67
Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic review 67
Enlarging the clinical spectrum of chorea-acanthocytosis 66
Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes 66
Teaching NeuroImages: Pseudohypertrophic cerebral cortex in end-stage Creutzfeldt-Jakob disease 66
A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide. 66
Adjunctive brivaracetam and sustained seizure frequency reduction in very active focal epilepsy 66
Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta-analysis of risk factors 65
Topographic divergence of atypical cortical asymmetry and atrophy patterns in temporal lobe epilepsy 65
Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: A consensus report from the International League Against Epilepsy Neuroimaging Task Force. 64
Deep Learning Representation from Electroencephalography of Early-Stage Creutzfeldt-Jakob Disease and Features for Differentiation from Rapidly Progressive Dementia. 64
Deep learning representation from electroencephalography of early-stage creutzfeldt-jakob disease and features for differentiation from rapidly progressive dementia 64
The mystery of unexplained traumatic sudden falls. A clinical case that adds a new feasible cause 63
Clinical utility of home videos for diagnosing epileptic seizures: a systematic review and practical recommendations for optimal and safe recording 63
Blocking out the real diagnosis 62
Integrity of the corpus callosum in patients with benign temporal lobe epilepsy 61
The parkin gene is not involved in late-onset Parkinson’s disease 61
A familial t(4;8) translocation segregates with epilepsy and migraine with aura 61
Predictors of Seizure Recurrence in Women With Idiopathic Generalized Epilepsy Who Switch From Valproate to Another Medication 61
PCDH19 mutations in female patients from Southern Italy. 60
Determinants of health-related quality of life in pharmacoresistant epilepsy: Results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments 60
Serum MicroRNAs as Predictors of Diagnosis and Drug-resistance in Temporal Lobe Epilepsy: A Preliminary Study 59
Effectiveness and safety of adjunctive cenobamate in people with focal-onset epilepsy: Interim results after 24-week observational period from the BLESS study 59
Brand-to-Generic Levetiracetam Switching: a four-years prospective observational real-life study 59
Profile of brivaracetam and its potential in the treatment of epilepsy 59
The ENIGMA-Epilepsy working group: Mapping disease from large data sets 59
May anti‐seizure medications alter brain structure in temporal lobe epilepsy? A prospective study 58
AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives 58
A novel mutation in the notch3 gene in an Italian family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: genetic and MRI spectroscopic analyses 58
The impact of one-year COVID-19 containment measures in patients with mesial temporal lobe epilepsy: A longitudinal survey-based study 58
Polymorphism of the multidrug resistance 1 gene MDR1/ABCB1 C3435T and response to antiepileptic drug treatment in temporal lobe epilepsy 57
Why should we change the term psychogenic nonepileptic seizures (PNES)? 57
Psychiatric Assessment in Patients with Mild Temporal Lobe Epilepsy 57
Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures 57
Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study 57
Orbito-frontal thinning together with a somatoform dissociation might be the fingerprint of PNES 57
The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy 56
Genome-wide association meta-analyses of drug-resistant epilepsy 56
Value of multimodal imaging approach to diagnosis of neurosarcoidosis 56
Midbrain meningioma causing subacute parkinsonism 56
Psychopathological constellation in Psychogenic Non-Epileptic Seizures 56
Second-Line Medications for Women Aged 10 to 50 Years with Idiopathic Generalized Epilepsy 55
Topiramate ban in women of childbearing potential with idiopathic generalized epilepsy: Does effectiveness offset the teratogenic risks? 55
Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) 55
Permutation entropy of scalp EEG: A tool to investigate epilepsies: Suggestions from absence epilepsies. 55
Acute bulbar palsy without ophtalmoplegia associated with anti-GD3 IgM antibodies. 55
Levetiracetam in patients with generalised epilepsy and myoclonic seizures: a open label study 55
Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis 54
Usefulness of a morning routine EEG recording in patients with juvenile myoclonic epilepsy. 54
Advanced MRI Morphologic Study Shows No Atrophy in Healthy Individuals with Hippocampal Hyperintensity 54
Structural brain abnormalities in the common epilepsies assessed in 3,876 individuals worldwide 54
Tacrolimus-induced polyneuropathy after heart transplantation 54
GABA(B) receptor 1 polymorphism (G1465A) is associated with temporal lobe epilepsy 54
Atlas of lesion locations and postsurgical seizure freedom in focal cortical dysplasia: A MELD study 54
Homozygous c.649dupC mutation in PRRT2 worsens the BFIS/PKD phenotype with mental retardation, episodic ataxia, and absences 53
Neuropsychological profile of mild temporal lobe epilepsy 53
Non-paraneoplastic limbic encephalitis characterized by mesio-temporal seizures and extratemporal lesions: a case report 53
Anti-GM1 antibodies are not associated with cerebral atrophy in patients with multiple sclerosis 53
Brainstem Posterior Reversible Encephalopathy Syndrome in an Asymptomatic Patient. 53
Corrigendum to “Advanced morphological neuroimaging study in lateral temporal lobe epilepsy: A multicentric study” [Epilepsy Behav 74 (2017) Pages 69–72] 53
Utility and limitations of homemade videos in differentiating functional seizures from other paroxysmal events: An Italian cohort study 52
Electroclinical Features and Long-term Seizure Outcome in Patients With Eyelid Myoclonia With Absences 52
Lamotrigine vs levetiracetam in female patients of childbearing age with juvenile absence epilepsy: A Bayesian reanalysis 52
White Matter Abnormalities Differentiate Severe from Benign Temporal Lobe Epilepsy. 52
Gerstmann-Straussler-Scheinker disease with PRNP P102L heterozygous mutation presenting as progressive myoclonus epilepsy. 52
Totale 7.029
Salva come PNG Salva come JPEG
Categoria #
all - tutte 131.308
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.308
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022651 0 0 0 173 66 13 13 133 81 63 104 5
2022/20231.784 446 94 44 202 207 175 4 110 271 102 107 22
2023/2024828 167 119 83 51 56 189 16 30 9 17 26 65
2024/20253.104 365 216 168 146 212 409 127 94 352 222 267 526
2025/20266.452 332 663 895 1.069 594 226 815 358 778 423 191 108
2026/2027698 105 413 180 0 0 0 0 0 0 0 0 0
Totale 13.944